The incorporation of methacrylated L-DOPA into injectable biomaterials results in enhanced cell adhesion, enables the encapsulation of active compounds, and facilitates the localized delivery of therapeutic agents . While hybrids derived from natural proteins and a variety of organic polymers show great potential, their expanded applications depend mainly on biocompatibility assessment. A key attribute is their ability to biodegrade within a certain time frame. This attribute is of great importance, especially for the use of such hybrids as materials for tissue regeneration.